- 专利标题： Methods of treating Fabry patients having renal impairment
-
申请号： US17077389申请日： 2020-10-22
-
公开(公告)号： US11612594B2公开(公告)日： 2023-03-28
- 发明人: Jeff Castelli , Elfrida Benjamin
- 申请人： Amicus Therapeutics, Inc.
- 申请人地址： US NJ Cranbury
- 专利权人： Amicus Therapeutics, Inc.
- 当前专利权人： Amicus Therapeutics, Inc.
- 当前专利权人地址： US NJ Cranbury
- 代理机构： Servilla Whitney LLC
- 主分类号： A61K31/445
- IPC分类号： A61K31/445 ; A61P13/12 ; A61K9/48
摘要：
Provided are methods for treatment of Fabry disease in patients having HEK assay amenable mutations in α-galactosidase A. Certain methods comprise administering migalastat or a salt thereof every other day, such as administering about 150 mg of migalastat hydrochloride every other day.
公开/授权文献
信息查询
IPC分类:
